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To the editor
We note emerging reports, including in this journal, of a high prevalence of post-traumatic
stress disorder (PTSD) and post-traumatic stress (PTS) symptoms in patients with COVID-19
(Bo et al., 2020; Wesemann et al., 2020). These reports arise in the context of previous corona-
virus pandemics in which PTSD occurred with a point-prevalence of 32.2% (Rogers et al.,
2020). Although it may be presumed that this increased risk would translate across to
COVID-19 patients, potential factors underlying this heightened vulnerability have received
minimal attention.
It is well-recognised that severe critical illness can cause lasting psychological trauma. PTSD
is an established sequela of intensive care admission, with pooled prevalence estimates of 17–
44% after intensive care unit (ICU) care (Parker et al., 2015). The similarity of this prevalence
range to that arising after SARS-CoV infection (Rogers et al., 2020) prompted the hypothesis
that ICU admission could be a key driving factor behind the high prevalence of PTSD/PTS in
patients with COVID-19. This hypothesis would predict that most patients with COVID-19
who develop PTSD/PTS were at one point critically ill and subsequently admitted to ICU.
However, this has not been definitively established.
We are a research collaboration of clinical academics evaluating the neurology and neuro-
psychiatry of COVID-19. Our platform allows us to examine emerging trends in the
COVID-19 neuropsychiatry literature (Butler et al., 2020). During that process and in partial
contrast to the hypothesis that illness severity is the key driving factor in the development of
PTSD, recent reports have emerged of PTS in patients with mild-moderate COVID-19.
Estimates of the frequency of psychological trauma after mild-moderate disease currently
vary. For example, Liu et al. (2020) evaluated PTS in 675 patients with predominantly mild-
moderate COVID-19 disease, using the PTSD Checklist for DSM-5 (PCL-5). They found that
12.4% of patients had clinically meaningful PTS. By contrast, a far higher prevalence was
reported by Bo et al. (2020) in this journal, who used the civilian version of a PTSD question-
naire based on DSM-IV (PCL-C). These authors found a prevalence of PTS of 96.2% in 714
patients with mild-moderate COVID-19 admitted to a government quarantine facility. How
should we evaluate such a wide discrepancy?
Explanations may include methodological differences in how PTS symptoms were mea-
sured, the point within the course of COVID-19 when patients were assessed, and the setting
in which assessment occurred. The studies by Liu et al. (2020) and Bo et al. (2020) used dif-
ferent and not directly comparable measures of PTS, and adopted different thresholds for
‘caseness’. The clinical populations were measured at different points in the course of
COVID-19: Bo et al. (2020) assessed patients prior to discharge; the markedly higher preva-
lence in their study may have captured acute psychological distress during hospitalisation.
Liu et al. (2020) assessed patients 1 month after discharge, capturing persistent symptoms
only (and with arguably a more stringent definition of casesness). Finally, they were assessed
in different settings. Government quarantine facilities (Bo et al., 2020) may provide only essen-
tial functions and might be a more distressing environment than being in a general hospital
(Liu et al., 2020). These factors – case definition, point of assessment and place of treatment –
presumably account for at least some of the heterogeneity in prevalence between the two studies.
Nevertheless, they converge on the suggestion of frequent symptoms of PTS even in patients with
mild-moderate COVID-19.
Other studies report high frequencies of PTS, but do not clearly describe COVID-19 sever-
ity. Wesemann et al. (2020) used the PCL-5 and found significant PTS in 8/19 (42%)
COVID-19 patients shortly after their presentation to hospital, whereas Chang and Park
(2020) used the PCL-5 to identify PTS in 13/64 (20%) patients assessed 10 weeks after dis-
charge. Either study neither described COVID-19 severity nor indicated the requirement for
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critical care. Liu et al. (2020) reported both, but found that sever-
ity of COVID-19 was a significant risk factor for PTS (OR = 3.27),
while ICU admission was not. This was surprising given the
assumption that severity of COVID-19 and ICU admission corre-
lates highly, and warrants further study.
Therefore at present, it is difficult to fully appraise the influence
of COVID-19 severity to the development of PTSD. If potential
factors underlying higher risk can be identified, it may be possible
to identify patients vulnerable to developing persisting trauma, and
intervene early. Several mechanisms have been advanced to explain
how PTSD/PTS arises in patients with COVID-19. Biological and
environmental factors may play a role, including in those with
mild-moderate COVID-19. COVID-19 wards are characterised by
patient isolation, use of extensive personal protective equipment
by staff and lack of accessibility to relatives and visitors in hospital.
Related to this alien environment, a contributory factor may be
delirium. Several reports have demonstrated a high prevalence of
delirium in COVID-19, not limited to patients in ICU but also
affecting patients in general hospital wards with less severe disease
(Mcloughlin et al., 2020). There is an emerging body of literature
demonstrating that PTSD can be a complication of delirium
(Bolton, Thilges, Lane, Lowe, & Mumby, 2019). Consequently, it
would be interesting to ascertain whether delirium is associated
with a greater likelihood of lasting psychological trauma in the spe-
cific context of COVID-19.
Taken together, the literature on PTSD/PTS in COVID-19 is
still evolving. There is a natural tendency to assume that ICU
admission and more severe disease will drive higher frequencies
of lasting PTSD, and this may well be true, but we have noted
emerging reports of a significant burden of psychological trauma
in patients with less severe COVID-19. The importance of this
phenomenon includes the opportunity it brings for early recogni-
tion and support, but also the implication for service planning:
the number of mild-moderate COVID-19 patients will dwarf
the number of patients requiring ICU, meaning that the former
group may comprise the larger aggregate demand on healthcare
and social resources. It is critical that we continue researching
the complex milieu of biological and environmental factors
which underlie heightened vulnerability to persisting PTS, includ-
ing the potential mediating role of COVID-19 severity.
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